The Wellcome Trust, in partnership with the University of Cambridge and GlaxoSmithKline, have funded an interdisciplinary training programme in Translational Medicine and Therapeutics (TMAT) with the objective of creating a cadre of outstanding clinical scientists with the skills to ‘translate science into medicines’. A key aspect of the Training is the MPhil course in TMAT consisting of taught modules by leading academics and clinicians across Cambridge and GSK, two exams, one project and a final dissertation. The curriculum covers all aspects of TMAT, from basic pharmacological principles and drug development, to designing and running clinical trials. Each student will work closely with a supervisor to develop a tailored training programme. Every year students will have opportunities to apply to continue their training to doctoral level.
Students will be based at the Addenbrooke’s Centre for Clinical Investigation. This building was funded by the MRC, BHF, Wellcome Trust and GSK to promote collaboration among its constituent University, NHS, and GSK groups.
Entry Requirements
This course is open to medical and non-medical graduates. Basic entry requirements are mandatory. A first degree of at least 2i honours form a UK University or equivalent demonstration of academic capability is required. Non-medical applicants generally have degrees in a quantitative science or a health related area. Other applicants will be judged on an individual basis depending on relevant previous experience.
Scholarship Application Deadline: 1 March 2011
